Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 10/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2184040 | 0.73 | TLR2 (0.47) | TLR2FOLH1ALDH1A1SLC6A5MMP2 | |
| SCHEMBL8680643 | 0.69 | ALDH1A1 (0.55) | FOLH1ALDH1A1 | |
| SCHEMBL6259652 | 0.69 | ALDH1A1 (0.55) | FOLH1ALDH1A1 | |
| SCHEMBL5187817 | 0.68 | ALDH1A1 (0.49) | FOLH1ALDH1A1 | |
| Octadecylamine SCHEMBL30381430 | 0.68 | ALDH1A1 (0.55) | ALDH1A1 | |
| Phthalic Acid SCHEMBL11415642 | 0.68 | ALDH1A1 (0.55) | ALDH1A1 | |
| Dodecylamine SCHEMBL5968460 | 0.68 | ALDH1A1 (0.55) | ALDH1A1 | |
| Octadecylamine SCHEMBL30381571 | 0.68 | ALDH1A1 (0.55) | ALDH1A1 | |
| Octadecylamine SCHEMBL4067737 | 0.68 | ALDH1A1 (0.55) | ALDH1A1 | |
| SCHEMBL7102378 | 0.68 | FOLH1 (0.48) | TLR2FOLH1ALDH1A1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100330033-A1 | Protein-carrier conjugates | WU NIAN | 2010-12-30 | — | — | US | disclosed |
| WO-2010120365-A2 | PROTEIN-CARRIER CONJUGATES | WU NIAN (US) | 2010-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330033-A1 | Protein-carrier conjugates | CHLSN, PCTP, CETP | TLR2 3790/4885FOLH1 88/4885ITGB3 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.